Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Loss of gut barrier integrity triggers activation of islet-reactive T cells and autoimmune diabetes.

Sorini C, Cosorich I, Lo Conte M, De Giorgi L, Facciotti F, Lucianò R, Rocchi M, Ferrarese R, Sanvito F, Canducci F, Falcone M.

Proc Natl Acad Sci U S A. 2019 Jul 23;116(30):15140-15149. doi: 10.1073/pnas.1814558116. Epub 2019 Jun 10.

2.

Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression.

Calcinotto A, Brevi A, Chesi M, Ferrarese R, Garcia Perez L, Grioni M, Kumar S, Garbitt VM, Sharik ME, Henderson KJ, Tonon G, Tomura M, Miwa Y, Esplugues E, Flavell RA, Huber S, Canducci F, Rajkumar VS, Bergsagel PL, Bellone M.

Nat Commun. 2018 Dec 3;9(1):4832. doi: 10.1038/s41467-018-07305-8.

3.

Probiotics, prebiotics and synbiotics for weight loss and metabolic syndrome in the microbiome era.

Ferrarese R, Ceresola ER, Preti A, Canducci F.

Eur Rev Med Pharmacol Sci. 2018 Nov;22(21):7588-7605. doi: 10.26355/eurrev_201811_16301.

4.

Targeting patients' microbiota with probiotics and natural fibers in adults and children with constipation.

Ceresola ER, Ferrarese R, Preti A, Canducci F.

Eur Rev Med Pharmacol Sci. 2018 Oct;22(20):7045-7057. doi: 10.26355/eurrev_201810_16177.

5.

Increased iNKT17 Cell Frequency in the Intestine of Non-Obese Diabetic Mice Correlates With High Bacterioidales and Low Clostridiales Abundance.

De Giorgi L, Sorini C, Cosorich I, Ferrarese R, Canducci F, Falcone M.

Front Immunol. 2018 Jul 30;9:1752. doi: 10.3389/fimmu.2018.01752. eCollection 2018.

6.

Rhodanine derivatives as potent anti-HIV and anti-HSV microbicides.

Tintori C, Iovenitti G, Ceresola ER, Ferrarese R, Zamperini C, Brai A, Poli G, Dreassi E, Cagno V, Lembo D, Canducci F, Botta M.

PLoS One. 2018 Jun 5;13(6):e0198478. doi: 10.1371/journal.pone.0198478. eCollection 2018.

7.

Testicular microbiome in azoospermic men-first evidence of the impact of an altered microenvironment.

Alfano M, Ferrarese R, Locatelli I, Ventimiglia E, Ippolito S, Gallina P, Cesana D, Canducci F, Pagliardini L, Viganò P, Clementi M, Nebuloni M, Montorsi F, Salonia A.

Hum Reprod. 2018 Jul 1;33(7):1212-1217. doi: 10.1093/humrep/dey116.

8.

Fecal Clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome.

Gargari G, Taverniti V, Gardana C, Cremon C, Canducci F, Pagano I, Barbaro MR, Bellacosa L, Castellazzi AM, Valsecchi C, Tagliacarne SC, Bellini M, Bertani L, Gambaccini D, Marchi S, Cicala M, Germanà B, Dal Pont E, Vecchi M, Ogliari C, Fiore W, Stanghellini V, Barbara G, Guglielmetti S.

Environ Microbiol. 2018 Sep;20(9):3201-3213. doi: 10.1111/1462-2920.14271. Epub 2018 Sep 24.

9.

Prenylated phloroglucinols from Hypericum scruglii, an endemic species of Sardinia (Italy), as new dual HIV-1 inhibitors effective on HIV-1 replication.

Sanna C, Scognamiglio M, Fiorentino A, Corona A, Graziani V, Caredda A, Cortis P, Montisci M, Ceresola ER, Canducci F, Poli F, Tramontano E, Esposito F.

PLoS One. 2018 Mar 30;13(3):e0195168. doi: 10.1371/journal.pone.0195168. eCollection 2018.

10.

IL28B rs12979860 genotype as a predictor marker of progression to BKVirus Associated nephropathy, after kidney transplantation.

Dvir R, Paloschi V, Canducci F, Dell'Antonio G, Racca S, Caldara R, Pantaleo G, Clementi M, Secchi A.

Sci Rep. 2017 Jul 27;7(1):6746. doi: 10.1038/s41598-017-06915-4.

11.

High frequency of intestinal TH17 cells correlates with microbiota alterations and disease activity in multiple sclerosis.

Cosorich I, Dalla-Costa G, Sorini C, Ferrarese R, Messina MJ, Dolpady J, Radice E, Mariani A, Testoni PA, Canducci F, Comi G, Martinelli V, Falcone M.

Sci Adv. 2017 Jul 12;3(7):e1700492. doi: 10.1126/sciadv.1700492. eCollection 2017 Jul.

12.

Revealing enterovirus infection in chronic human disorders: An integrated diagnostic approach.

Genoni A, Canducci F, Rossi A, Broccolo F, Chumakov K, Bono G, Salerno-Uriarte J, Salvatoni A, Pugliese A, Toniolo A.

Sci Rep. 2017 Jul 10;7(1):5013. doi: 10.1038/s41598-017-04993-y.

13.

The Microbiome of the Prostate Tumor Microenvironment.

Cavarretta I, Ferrarese R, Cazzaniga W, Saita D, Lucianò R, Ceresola ER, Locatelli I, Visconti L, Lavorgna G, Briganti A, Nebuloni M, Doglioni C, Clementi M, Montorsi F, Canducci F, Salonia A.

Eur Urol. 2017 Oct;72(4):625-631. doi: 10.1016/j.eururo.2017.03.029. Epub 2017 Apr 20.

PMID:
28434677
14.

One drug for two targets: Biological evaluation of antiretroviral agents endowed with antiproliferative activity.

Botta L, Maccari G, Calandro P, Tiberi M, Brai A, Zamperini C, Canducci F, Chiariello M, Martí-Centelles R, Falomir E, Carda M.

Bioorg Med Chem Lett. 2017 Jun 1;27(11):2502-2505. doi: 10.1016/j.bmcl.2017.03.097. Epub 2017 Apr 1.

PMID:
28408224
15.

Duodenal Mucosa of Patients With Type 1 Diabetes Shows Distinctive Inflammatory Profile and Microbiota.

Pellegrini S, Sordi V, Bolla AM, Saita D, Ferrarese R, Canducci F, Clementi M, Invernizzi F, Mariani A, Bonfanti R, Barera G, Testoni PA, Doglioni C, Bosi E, Piemonti L.

J Clin Endocrinol Metab. 2017 May 1;102(5):1468-1477. doi: 10.1210/jc.2016-3222.

PMID:
28324102
16.

Natural Product Kuwanon-L Inhibits HIV-1 Replication through Multiple Target Binding.

Martini R, Esposito F, Corona A, Ferrarese R, Ceresola ER, Visconti L, Tintori C, Barbieri A, Calcaterra A, Iovine V, Canducci F, Tramontano E, Botta M.

Chembiochem. 2017 Feb 16;18(4):374-377. doi: 10.1002/cbic.201600592. Epub 2017 Jan 18.

PMID:
27992102
17.

Adaptive immunity against gut microbiota enhances apoE-mediated immune regulation and reduces atherosclerosis and western-diet-related inflammation.

Saita D, Ferrarese R, Foglieni C, Esposito A, Canu T, Perani L, Ceresola ER, Visconti L, Burioni R, Clementi M, Canducci F.

Sci Rep. 2016 Jul 7;6:29353. doi: 10.1038/srep29353.

18.

Inhibition of HIV-1 Reverse Transcriptase Dimerization by Small Molecules.

Tintori C, Corona A, Esposito F, Brai A, Grandi N, Ceresola ER, Clementi M, Canducci F, Tramontano E, Botta M.

Chembiochem. 2016 Apr 15;17(8):683-8. doi: 10.1002/cbic.201500668. Epub 2016 Mar 21.

PMID:
26946324
19.

Development and in Vitro Evaluation of a Microbicide Gel Formulation for a Novel Non-Nucleoside Reverse Transcriptase Inhibitor Belonging to the N-Dihydroalkyloxybenzyloxopyrimidines (N-DABOs) Family.

Tintori C, Brai A, Dasso Lang MC, Deodato D, Greco AM, Bizzarri BM, Cascone L, Casian A, Zamperini C, Dreassi E, Crespan E, Maga G, Vanham G, Ceresola E, Canducci F, Ariën KK, Botta M.

J Med Chem. 2016 Mar 24;59(6):2747-59. doi: 10.1021/acs.jmedchem.5b01979. Epub 2016 Mar 8.

PMID:
26898379
20.

Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment.

Dolpady J, Sorini C, Di Pietro C, Cosorich I, Ferrarese R, Saita D, Clementi M, Canducci F, Falcone M.

J Diabetes Res. 2016;2016:7569431. doi: 10.1155/2016/7569431. Epub 2015 Dec 8.

21.

The interplay of extracellular matrix and microbiome in urothelial bladder cancer.

Alfano M, Canducci F, Nebuloni M, Clementi M, Montorsi F, Salonia A.

Nat Rev Urol. 2016 Feb;13(2):77-90. doi: 10.1038/nrurol.2015.292. Epub 2015 Dec 15. Review.

PMID:
26666363
22.

Kuwanon-L as a New Allosteric HIV-1 Integrase Inhibitor: Molecular Modeling and Biological Evaluation.

Esposito F, Tintori C, Martini R, Christ F, Debyser Z, Ferrarese R, Cabiddu G, Corona A, Ceresola ER, Calcaterra A, Iovine V, Botta B, Clementi M, Canducci F, Botta M, Tramontano E.

Chembiochem. 2015 Nov;16(17):2507-12. doi: 10.1002/cbic.201500385. Epub 2015 Oct 26.

PMID:
26360521
23.

Comparison of the artus HIV-1 QS-RGQ and VERSANT HIV-1 RNA 1.0 assays for quantitative detection of human immunodeficiency virus type 1 in plasma samples.

Dvir R, Canducci F, Racca S, Rolla S, Stucchi S, Clementi M.

New Microbiol. 2015 Jul;38(3):337-44. Epub 2015 Jul 6.

24.

HIV DNA loads, plasma residual viraemia and risk of virological rebound in heavily treated, virologically suppressed HIV-infected patients.

Gianotti N, Canducci F, Galli L, Cossarini F, Salpietro S, Poli A, Nozza S, Spagnuolo V, Clementi M, Sampaolo M, Ceresola ER, Racca S, Lazzarin A, Castagna A.

Clin Microbiol Infect. 2015 Jan;21(1):103.e7-103.e10. doi: 10.1016/j.cmi.2014.08.004. Epub 2014 Oct 13.

25.

Performance of commonly used genotypic assays and comparison with phenotypic assays of HIV-1 coreceptor tropism in acutely HIV-1-infected patients.

Ceresola ER, Nozza S, Sampaolo M, Pignataro AR, Saita D, Ferrarese R, Ripa M, Deng W, Mullins JI, Boeri E, Tambussi G, Toniolo A, Lazzarin A, Clementi M, Canducci F.

J Antimicrob Chemother. 2015 May;70(5):1391-5. doi: 10.1093/jac/dku573. Epub 2015 Jan 20.

26.

2-Aminothiazolones as anti-HIV agents that act as gp120-CD4 inhibitors.

Tiberi M, Tintori C, Ceresola ER, Fazi R, Zamperini C, Calandro P, Franchi L, Selvaraj M, Botta L, Sampaolo M, Saita D, Ferrarese R, Clementi M, Canducci F, Botta M.

Antimicrob Agents Chemother. 2014 Jun;58(6):3043-52. doi: 10.1128/AAC.02739-13. Epub 2014 Mar 10.

27.

Immunological recovery after 24 weeks of antiretroviral therapy in patients with X4 virus during primary HIV infection.

Nozza S, Pignataro AR, Galli L, Ripa M, Boeri E, Chiappetta S, Galli A, Canducci F, Sampaolo M, Clementi M, Lazzarin A, Tambussi G.

J Acquir Immune Defic Syndr. 2014 Jan 1;65(1):e27-9. doi: 10.1097/QAI.0b013e3182a03ed2. No abstract available.

PMID:
24419069
28.

Virological rebound in human immunodeficiency virus-infected patients with or without residual viraemia: results from an extended follow-up.

Gianotti N, Galli L, Salpietro S, Cernuschi M, Bossolasco S, Maillard M, Spagnuolo V, Canducci F, Clementi M, Lazzarin A, Castagna A.

Clin Microbiol Infect. 2013 Dec;19(12):E542-4. doi: 10.1111/1469-0691.12266. Epub 2013 Jul 24.

29.

In vitro phenotypes to elvitegravir and dolutegravir in primary macrophages and lymphocytes of clonal recombinant viral variants selected in patients failing raltegravir.

Canducci F, Ceresola ER, Saita D, Castagna A, Gianotti N, Underwood M, Burioni R, Lazzarin A, Clementi M.

J Antimicrob Chemother. 2013 Nov;68(11):2525-32. doi: 10.1093/jac/dkt220. Epub 2013 Jun 24.

PMID:
23798668
30.

Infection and coinfection of human rhinovirus C in stem cell transplant recipients.

Canducci F, Debiaggi M, Ceresola ER, Sampaolo M, Alessandrino EP, Brerra R, Piazza A, Clementi M.

Clin Dev Immunol. 2013;2013:236081. doi: 10.1155/2013/236081. Epub 2013 Feb 27.

31.

The role of infections and coinfections with newly identified and emerging respiratory viruses in children.

Debiaggi M, Canducci F, Ceresola ER, Clementi M.

Virol J. 2012 Oct 27;9:247. doi: 10.1186/1743-422X-9-247. Review.

32.

Epidemiological, molecular and clinical features of enterovirus 109 infection in children and in adult stem cell transplant recipients.

Debiaggi M, Ceresola ER, Sampaolo M, Alessandrino EP, Brerra R, Piazza A, Clementi M, Canducci F.

Virol J. 2012 Sep 4;9:183. doi: 10.1186/1743-422X-9-183.

33.

Cross-reacting antibacterial auto-antibodies are produced within coronary atherosclerotic plaques of acute coronary syndrome patients.

Canducci F, Saita D, Foglieni C, Piscopiello MR, Chiesa R, Colombo A, Cianflone D, Maseri A, Clementi M, Burioni R.

PLoS One. 2012;7(8):e42283. doi: 10.1371/journal.pone.0042283. Epub 2012 Aug 6.

34.

A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments.

Solforosi L, Mancini N, Canducci F, Clementi N, Sautto GA, Diotti RA, Clementi M, Burioni R.

New Microbiol. 2012 Jul;35(3):289-94. Epub 2012 Jun 30.

35.

Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 counts.

Nozza S, Canducci F, Galli L, Cozzi-Lepri A, Capobianchi MR, Ceresola ER, Narciso P, Libertone R, Castelli P, Moioli M, D'Arminio Monforte A, Castagna A; ICONA Foundation.

J Antimicrob Chemother. 2012 May;67(5):1224-7. doi: 10.1093/jac/dkr600. Epub 2012 Jan 31.

PMID:
22298348
36.

Residual viraemia does not influence 1 year virological rebound in HIV-infected patients with HIV RNA persistently below 50 copies/mL.

Gianotti N, Galli L, Racca S, Salpietro S, Cossarini F, Spagnuolo V, Barda B, Canducci F, Clementi M, Lazzarin A, Castagna A.

J Antimicrob Chemother. 2012 Jan;67(1):213-7. doi: 10.1093/jac/dkr422. Epub 2011 Oct 10.

PMID:
21987242
37.

Cross-resistance profile of the novel integrase inhibitor Dolutegravir (S/GSK1349572) using clonal viral variants selected in patients failing raltegravir.

Canducci F, Ceresola ER, Boeri E, Spagnuolo V, Cossarini F, Castagna A, Lazzarin A, Clementi M.

J Infect Dis. 2011 Dec 1;204(11):1811-5. doi: 10.1093/infdis/jir636. Epub 2011 Oct 7.

PMID:
21984737
38.

The new and less toxic protease inhibitor saquinavir-NO maintains anti-HIV-1 properties in vitro indistinguishable from those of the parental compound saquinavir.

Canducci F, Ceresola ER, Saita D, Al-Abed Y, Garotta G, Clementi M, Nicoletti F.

Antiviral Res. 2011 Sep;91(3):292-5. doi: 10.1016/j.antiviral.2011.07.001. Epub 2011 Jul 8.

PMID:
21763726
39.

Integrase and fusion inhibitors transmitted drug resistance in naive patients with recent diagnosis of HIV-1 infection.

Cossarini F, Boeri E, Canducci F, Salpietro S, Bigoloni A, Galli L, Spagnuolo V, Castagna A, Clementi M, Lazzarin A, Gianotti N.

J Acquir Immune Defic Syndr. 2011 Feb 1;56(2):e51-4. doi: 10.1097/QAI.0b013e3181fcc0f1. No abstract available.

PMID:
21233631
40.

Quantitative HIV-1 proviral DNA detection: a multicentre analysis.

De Rossi A, Zanchetta M, Vitone F, Antonelli G, Bagnarelli P, Buonaguro L, Capobianchi MR, Clementi M, Abbate I, Canducci F, Monachetti A, Riva E, Rozera G, Scagnolari C, Tagliamonte M, Re MC; SIVIM (Italian Society of Medical Virology) Group.

New Microbiol. 2010 Oct;33(4):293-302.

41.

Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group.

Svicher V, D'Arrigo R, Alteri C, Andreoni M, Angarano G, Antinori A, Antonelli G, Bagnarelli P, Baldanti F, Bertoli A, Borderi M, Boeri E, Bonn I, Bruzzone B, Callegaro AP, Cammarota R, Canducci F, Ceccherini-Silberstein F, Clementi M, Monforte AD, De Luca A, Di Biagio A, Di Gianbenedetto S, Di Perri G, Di Pietro M, Fabeni L, Fadda G, Galli M, Gennari W, Ghisetti V, Giacometti A, Gori A, Leoncini F, Maggiolo F, Maserati R, Mazzotta F, Micheli V, Meini G, Monno L, Mussini C, Nozza S, Paolucci S, Parisi S, Pecorari M, Pizzi D, Quirino T, Re MC, Rizzardini G, Santangelo R, Soria A, Stazi F, Sterrantino G, Turriziani O, Viscoli C, Vullo V, Lazzarin A, Perno CF; OSCAR Study Group.

New Microbiol. 2010 Jul;33(3):195-206.

42.

Evolution patterns of raltegravir-resistant mutations after integrase inhibitor interruption.

Canducci F, Barda B, Ceresola E, Spagnuolo V, Sampaolo M, Boeri E, Nozza S, Cossarin F, Galli A, Gianotti N, Castagna A, Lazzarin A, Clementi M.

Clin Microbiol Infect. 2011 Jun;17(6):928-34. doi: 10.1111/j.1469-0691.2010.03375.x. Epub 2010 Nov 5.

43.

Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experience.

Nozza S, Galli L, Visco F, Soria A, Canducci F, Salpietro S, Gianotti N, Bigoloni A, Torre LD, Tambussi G, Lazzarin A, Castagna A.

AIDS. 2010 Mar 27;24(6):924-8. doi: 10.1097/QAD.0b013e3283372d76.

PMID:
20154578
44.

Molecular cloning of the first human monoclonal antibodies neutralizing with high potency swine-origin influenza A pandemic virus (S-OIV).

Burioni R, Canducci F, Mancini N, Clementi N, Sassi M, De Marco D, Saita D, Diotti RA, Sautto G, Sampaolo M, Clementi M.

New Microbiol. 2009 Oct;32(4):319-24.

45.

Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV).

Burioni R, Canducci F, Mancini N, Clementi N, Sassi M, De Marco D, Diotti RA, Saita D, Sampaolo M, Sautto G, Pianezze M, Clementi M.

Virology. 2010 Mar 30;399(1):144-152. doi: 10.1016/j.virol.2009.12.014. Epub 2010 Jan 22.

46.

Genotypic/phenotypic patterns of HIV-1 integrase resistance to raltegravir.

Canducci F, Marinozzi MC, Sampaolo M, Boeri E, Spagnuolo V, Gianotti N, Castagna A, Paolucci S, Baldanti F, Lazzarin A, Clementi M.

J Antimicrob Chemother. 2010 Mar;65(3):425-33. doi: 10.1093/jac/dkp477. Epub 2010 Jan 7.

PMID:
20056687
47.

Molecular epidemiology of KI and WU polyomaviruses in infants with acute respiratory disease and in adult hematopoietic stem cell transplant recipients.

Debiaggi M, Canducci F, Brerra R, Sampaolo M, Marinozzi MC, Parea M, Arghittu M, Alessandrino EP, Nava S, Nucleo E, Romero E, Clementi M.

J Med Virol. 2010 Jan;82(1):153-6. doi: 10.1002/jmv.21659.

PMID:
19950241
48.

Pregnancy and H1N1 infection.

Burioni R, Canducci F, Clementi M.

Lancet. 2009 Oct 24;374(9699):1417; author reply 1417-8. doi: 10.1016/S0140-6736(09)61853-5. No abstract available.

PMID:
19854362
49.

Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques.

Burioni R, Canducci F, Saita D, Perotti M, Mancini N, De Marco D, Clementi N, Chieffo A, Denaro M, Cianflone D, Manfredi AA, Colombo A, Maseri A, Clementi M.

J Immunol. 2009 Aug 15;183(4):2537-44. doi: 10.4049/jimmunol.0901076. Epub 2009 Jul 27.

50.

Dynamic patterns of human immunodeficiency virus type 1 integrase gene evolution in patients failing raltegravir-based salvage therapies.

Canducci F, Sampaolo M, Marinozzi MC, Boeri E, Spagnuolo V, Galli A, Castagna A, Lazzarin A, Clementi M, Gianotti N.

AIDS. 2009 Feb 20;23(4):455-60. doi: 10.1097/QAD.0b013e328323da60.

PMID:
19165083

Supplemental Content

Loading ...
Support Center